Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 15;12(11):154.
doi: 10.1038/s41408-022-00749-8.

Breakthrough infections in MPN-COVID vaccinated patients

Tiziano Barbui  1 Alessandra Carobbio  2 Arianna Ghirardi  2 Alessandra Iurlo  3 Valerio De Stefano  4 Marta Anna Sobas  5 Elisa Rumi  6 Elena Maria Elli  7 Francesca Lunghi  8 Mercedes Gasior Kabat  9 Beatriz Cuevas  10 Paola Guglielmelli  11 Massimiliano Bonifacio  12 Monia Marchetti  13 Alberto Alvarez-Larran  14 Laura Fox  15 Marta Bellini  16 Rosa Daffini  17 Giulia Benevolo  18 Gonzalo Carreno-Tarragona  19 Andrea Patriarca  20 Haifa Kathrin Al-Ali  21 Maria Marcio Miguel Andrade-Campos  22 Francesca Palandri  23 Claire Harrison  24 Maria Angeles Foncillas  25 Santiago Osorio  26 Steffen Koschmieder  27 Elena Magro Mazo  28 Jean-Jacques Kiladjian  29 Estefanía Bolaños Calderón  30 Florian H Heidel  31 Keina Quiroz Cervantes  32 Martin Griesshammer  33 Valentin Garcia-Gutierrez  34 Alberto Marin Sanchez  35 Juan Carlos Hernandez-Boluda  36 Emma Lopez Abadia  37 Giuseppe Carli  38 Miguel Sagues Serrano  39 Rajko Kusec  40 Blanca Xicoy Cirici  41 Margarita Guenova  42 Begona Navas Elorza  43 Anna Angona  44 Edyta Cichocka  45 Anna Kulikowska de Nałęcz  46 Daniele Cattaneo  3   47 Cristina Bucelli  3 Silvia Betti  4 Oscar Borsani  6 Fabrizio Cavalca  7 Sara Carbonell  14 Natalia Curto-Garcia  24 Lina Benajiba  29 Alessandro Rambaldi  16   47 Alessandro Maria Vannucchi  11
Affiliations

Breakthrough infections in MPN-COVID vaccinated patients

Tiziano Barbui et al. Blood Cancer J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Barbui T, Vannucchi AM, Alvarez-Larran A, Iurlo A, Masciulli A, Carobbio A, et al. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021;35:485–93. doi: 10.1038/s41375-020-01107-y. - DOI - PMC - PubMed
    1. Barbui T, Carobbio A, Ghirardi A, Iurlo A, Sobas MA, Elli EM, et al. Determinants of early triage for hospitalization in MPN patients with COVID-19. Am J Hematol 2022. 10.1002/ajh.26732. - PMC - PubMed
    1. Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, et al. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study. Clin Microbiol Infect. 2020;26:1663–9. doi: 10.1016/j.cmi.2020.08.011. - DOI - PMC - PubMed
    1. Barbui T, Iurlo A, Masciulli A, Carobbio A, Ghirardi A, Carioli G, et al. Second versus first wave of COVID-19 in patients with MPN. Leukemia. 2022;36:897–900. doi: 10.1038/s41375-022-01507-2. - DOI - PMC - PubMed
    1. Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022;399:814–23. doi: 10.1016/S0140-6736(22)00089-7. - DOI - PMC - PubMed

Publication types